How do extractables and leachables testing requirements affect supplier selection in the Single Use Bioprocessing Market?

Buyers should prioritize suppliers offering pre-validated extractables profiles with documented USP <665> and BPOG-standardized data packages. Suppliers providing component-level E&L data reduce internal qualification timelines by 4–6 months [18]. Read More

What procurement strategies help mitigate polymer supply disruption risks?

Dual-sourcing bioreactor film from geographically separated suppliers is the primary risk mitigation approach. Facilities maintaining 8–12 weeks of safety stock for critical bag assemblies reported minimal production impact during the 2025 supply disruption [17]. Read More

How does the Single Use Bioprocessing Market address viral vector manufacturing requirements differently from monoclonal antibodies?

Viral vector production requires specialized containment-rated single-use assemblies with validated inactivation protocols at every open-transfer point. Closed-system kits designed for lentiviral and AAV production carry 25–35% price premiums over standard mAb-grade assemblies [11]. Read More

What is the total cost of ownership comparison between single-use and stainless-steel facilities?

Single-use facilities reduce upfront capital expenditure by 40–50% and cut time-to-GMP-readiness by 12–18 months. Operating costs per batch are 10–15% higher due to consumable spend, but faster changeover offsets this for multi-product operations [7]. Read More

How are sustainability certifications influencing purchasing decisions in the Single Use Bioprocessing Market?

European buyers increasingly require ISO 14001 certification and documented carbon footprint data from single-use suppliers. Approximately 30% of EU-based procurement RFPs in 2025 included sustainability scoring criteria for single-use consumable vendors [12]. Read More

What role do connector standardization initiatives play in reducing vendor lock-in?

Industry groups like BPSA are advancing aseptic connector interoperability standards. Standardized connector interfaces allow facilities to mix components across suppliers, reducing single-vendor dependency by an estimated 20–30% [14]. Read More

How will continuous bioprocessing adoption reshape demand patterns in the Single Use Bioprocessing Market?

Continuous perfusion runs consume fewer but higher-specification consumables per campaign compared to batch processing. Demand shifts toward specialized perfusion-rated bags, hollow fiber cartridges, and long-duration inline sensors rather than volume-driven batch consumables [14]. Read More

What is the current size of the single use bioprocessing market?

The single use bioprocessing market reached USD 18.1 billion in 2025 and is projected to reach USD 119.8 billion by 2035. Read More

What is the CAGR of the single use bioprocessing market?

The single use bioprocessing market is projected to grow at a CAGR of 20.8% during the forecast period 2025–2035. Read More

Which region leads the single use bioprocessing market?

North America holds the largest share at 44.73%, while Asia-Pacific is the fastest-growing region. Read More

Single Use Bioprocessing Market (2026 - 2035)

ID: MRFR/HC/10810-HCR

128 Pages

Vikita Thakur

Last Updated: July 06, 2026

Single Use Bioprocessing Market Research Report Information By Product (Filtration Assemblies, Disposable Bioreactors, Disposable Mixers, Media Bags and Containers, and Others), By Application (Filtration, Purification, Cell Culture, and Others), By End-User (Biopharmaceutical Manufacturers, Clinical & Academic Research Institutes, and Others), By Workflow (Upstream, Fermentation, and Downstream) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2035

Single Use Bioprocessing Market

Market Size

Forecast Period2026-2035

CAGR (2026-2035)13.2%

2025 Market SizeUSD 31.23 Billion

2035 Market SizeUSD 107.83 Billion

Key Players

Sartorius AG

Cytiva

Thermo Fisher Scientific

Merck KGaA

Pall Corporation

Repligen Corporation

Trends

Biologics Pipeline Expansion
Regulatory Harmonization
CDMO Capacity Expansion

Opportunities

Cell and Gene Therapy Manufacturing
Continuous Bioprocessing Integration
Emerging-Market CDMO Expansion

Summary Table of Contents Segmentation Methodology Download PDF

1 Market Overview |
1. 1.1 Study Assumptions & Market Definition |
2. 1.2 Scope of the Study |
3. 1.3 Research Methodology
2 Market Summary & Key Takeaways
3 Market Dynamics |
1. 3.1 Market Drivers Analysis | |
  1. 3.1.1 Biologics Pipeline Expansion and mAb Commercialization | |
  2. 3.1.2 Regulatory Harmonization for Single-Use Validation | |
  3. 3.1.3 CDMO Capacity Expansion and Outsourcing Growth | |
  4. 3.1.4 AI-Enabled PAT and Smart Sensor Integration | |
  5. 3.1.5 Cell and Gene Therapy Manufacturing Scale-Up | |
  6. 3.1.6 Biosimilar Production Wave in Emerging Markets | |
  7. 3.1.7 Sustainability-Driven Polymer Recovery Mandates |
2. 3.2 Market Restraints Analysis | |
  1. 3.2.1 Medical-Grade Polymer Supply Concentration | |
  2. 3.2.2 Plastic Waste and Environmental Criticism | |
  3. 3.2.3 Bioreactor Scale Limitations Above 2,000 L | |
  4. 3.2.4 Extractables and Leachables Qualification Burden | |
  5. 3.2.5 Operator Training and Process Transfer Complexity |
3. 3.3 Market Opportunity Analysis | |
  1. 3.3.1 Cell and Gene Therapy Manufacturing | |
  2. 3.3.2 Continuous Bioprocessing Integration | |
  3. 3.3.3 Emerging-Market CDMO Expansion | |
  4. 3.3.4 Digital Twins and Data Monetization | |
  5. 3.3.5 Sustainability-Linked Product Innovation |
4. 3.4 Industry Value Chain Analysis |
5. 3.5 Porter's Five Forces Analysis
4 Global Single Use Bioprocessing Market Size & Forecast (2021–2035) |
1. 4.1 Historical Market Size (2021–2025) |
2. 4.2 Current & Forecast Market Size (2026–2035) |
3. 4.3 Market Size by Revenue (USD Billion) |
4. 4.4 Year-over-Year Growth Analysis
5 Segmentation Analysis |
1. 5.1 By Product | |
  1. 5.1.1 Single-Use Bioreactors | |
  2. 5.1.2 Filtration Assemblies | |
  3. 5.1.3 Sensors & Analytics | |
  4. 5.1.4 Bags, Tubing & Connectors | |
  5. 5.1.5 Mixing Systems |
2. 5.2 By Workflow Stage | |
  1. 5.2.1 Upstream Processing | |
  2. 5.2.2 Downstream Processing | |
  3. 5.2.3 Other Operations |
3. 5.3 By End User | |
  1. 5.3.1 Biopharmaceutical Companies | |
  2. 5.3.2 Contract Development and Manufacturing Organizations (CDMOs) | |
  3. 5.3.3 Academic & Research Institutions |
4. 5.4 By Scale | |
  1. 5.4.1 Commercial Scale | |
  2. 5.4.2 Clinical Scale
6 Regional Analysis |
1. 6.1 North America | |
  1. 6.1.1 United States | |
  2. 6.1.2 Canada | |
  3. 6.1.3 Mexico |
2. 6.2 Europe | |
  1. 6.2.1 Germany | |
  2. 6.2.2 United Kingdom | |
  3. 6.2.3 France | |
  4. 6.2.4 Italy | |
  5. 6.2.5 Spain | |
  6. 6.2.6 Nordic Countries | |
  7. 6.2.7 Russia | |
  8. 6.2.8 Rest of Europe |
3. 6.3 Asia-Pacific | |
  1. 6.3.1 China | |
  2. 6.3.2 India | |
  3. 6.3.3 Japan | |
  4. 6.3.4 South Korea | |
  5. 6.3.5 ASEAN | |
  6. 6.3.6 Rest of Asia-Pacific |
4. 6.4 South America | |
  1. 6.4.1 Brazil | |
  2. 6.4.2 Argentina | |
  3. 6.4.3 Rest of South America |
5. 6.5 Middle East & Africa | |
  1. 6.5.1 Saudi Arabia | |
  2. 6.5.2 UAE | |
  3. 6.5.3 South Africa | |
  4. 6.5.4 Egypt | |
  5. 6.5.5 Rest of MEA
7 Competitive Landscape |
1. 7.1 Market Share Analysis (2025) |
2. 7.2 Competitive Benchmarking Matrix |
3. 7.3 Company Profiles | |
  1. 7.3.1 Sartorius AG | |
  2. 7.3.2 Cytiva (Danaher) | |
  3. 7.3.3 Thermo Fisher Scientific | |
  4. 7.3.4 Merck KGaA (MilliporeSigma) | |
  5. 7.3.5 Pall Corporation (Danaher) | |
  6. 7.3.6 Repligen Corporation | |
  7. 7.3.7 Saint-Gobain Life Sciences | |
  8. 7.3.8 Parker Hannifin (BioScience) | |
  9. 7.3.9 Avantor (VWR) | |
  10. 7.3.10 Entegris
8 Future Outlook & Strategic Recommendations (2026–2035) |
1. 8.1 Autonomous Bioprocessing and AI Integration |
2. 8.2 Platform Standardization and Modular Facilities |
3. 8.3 Sustainability Transformation |
4. 8.4 Gene Therapy and Viral Vector Scale-Up
9 Recent Developments & News
10 Frequently Asked Questions (FAQs)
11 Report Scope & Methodology |
1. 11.1 Study Period & Base Year |
2. 11.2 Data Sources & Citations |
3. 11.3 Abbreviations
12 LIST OF TABLES |
TABLE 1 Global Single Use Bioprocessing Market Size & Forecast, by Revenue (USD Billion), 2021–2035 |
TABLE 2 Global Single Use Bioprocessing Market — Year-over-Year Growth Analysis, 2021–2035 |
TABLE 3 Global Single Use Bioprocessing Market — Driver Impact Analysis |
TABLE 4 Global Single Use Bioprocessing Market — Restraint Impact Analysis |
TABLE 5 Global Single Use Bioprocessing Market Size, by Product, 2021–2035 (USD Billion) |
TABLE 6 Global Single Use Bioprocessing Market Size, by Workflow Stage, 2021–2035 (USD Billion) |
TABLE 7 Global Single Use Bioprocessing Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 8 Global Single Use Bioprocessing Market Size, by Scale, 2021–2035 (USD Billion) |
TABLE 9 Global Single Use Bioprocessing Market Size, by Region, 2021–2035 (USD Billion) |
TABLE 10 North America Single Use Bioprocessing Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 11 Europe Single Use Bioprocessing Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 12 Asia-Pacific Single Use Bioprocessing Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 13 South America Single Use Bioprocessing Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 14 Middle East & Africa Single Use Bioprocessing Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 15 Competitive Benchmarking Matrix — Global Single Use Bioprocessing Market, 2025 |
TABLE 16 Company Profiles — Key Players, Global Single Use Bioprocessing Market |
TABLE 17 Recent Developments & Strategic Announcements, 2023–2025 |
TABLE 18 North America Single Use Bioprocessing Market Size, by Product, 2021–2035 (USD Billion) |
TABLE 19 North America Single Use Bioprocessing Market Size, by Workflow Stage, 2021–2035 (USD Billion) |
TABLE 20 North America Single Use Bioprocessing Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 21 North America Single Use Bioprocessing Market Size, by Scale, 2021–2035 (USD Billion) |
TABLE 22 Europe Single Use Bioprocessing Market Size, by Product, 2021–2035 (USD Billion) |
TABLE 23 Europe Single Use Bioprocessing Market Size, by Workflow Stage, 2021–2035 (USD Billion) |
TABLE 24 Europe Single Use Bioprocessing Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 25 Europe Single Use Bioprocessing Market Size, by Scale, 2021–2035 (USD Billion) |
TABLE 26 Asia-Pacific Single Use Bioprocessing Market Size, by Product, 2021–2035 (USD Billion) |
TABLE 27 Asia-Pacific Single Use Bioprocessing Market Size, by Workflow Stage, 2021–2035 (USD Billion) |
TABLE 28 Asia-Pacific Single Use Bioprocessing Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 29 Asia-Pacific Single Use Bioprocessing Market Size, by Scale, 2021–2035 (USD Billion) |
TABLE 30 South America Single Use Bioprocessing Market Size, by Product, 2021–2035 (USD Billion) |
TABLE 31 South America Single Use Bioprocessing Market Size, by Workflow Stage, 2021–2035 (USD Billion) |
TABLE 32 South America Single Use Bioprocessing Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 33 South America Single Use Bioprocessing Market Size, by Scale, 2021–2035 (USD Billion) |
TABLE 34 Middle East & Africa Single Use Bioprocessing Market Size, by Product, 2021–2035 (USD Billion) |
TABLE 35 Middle East & Africa Single Use Bioprocessing Market Size, by Workflow Stage, 2021–2035 (USD Billion) |
TABLE 36 Middle East & Africa Single Use Bioprocessing Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 37 Middle East & Africa Single Use Bioprocessing Market Size, by Scale, 2021–2035 (USD Billion) |
TABLE 38 Report Scope & Methodology Summary |
TABLE 39 Detailed Sources and Citations |
TABLE 40 Segmentation Quick Reference
13 LIST OF FIGURES |
FIGURE 1 Single Use Bioprocessing Market Dynamics — Drivers, Restraints, and Opportunities |
FIGURE 2 Single Use Bioprocessing Market — Industry Value Chain Analysis |
FIGURE 3 Single Use Bioprocessing Market — Porter's Five Forces Analysis |
FIGURE 4 Global Single Use Bioprocessing Market Size Trend (USD Billion), 2021–2035 |
FIGURE 5 Single Use Bioprocessing Market Share, by Product (2025) |
FIGURE 6 Single Use Bioprocessing Market Share, by Workflow Stage (2025) |
FIGURE 7 Single Use Bioprocessing Market Share, by End User (2025) |
FIGURE 8 Single Use Bioprocessing Market Share, by Scale (2025) |
FIGURE 9 Single Use Bioprocessing Market Share, by Region (2025) |
FIGURE 10 North America Single Use Bioprocessing Market Share, by Country (2025) |
FIGURE 11 Europe Single Use Bioprocessing Market Share, by Country (2025) |
FIGURE 12 Asia-Pacific Single Use Bioprocessing Market Share, by Country (2025) |
FIGURE 13 South America Single Use Bioprocessing Market Share, by Country (2025) |
FIGURE 14 Middle East & Africa Single Use Bioprocessing Market Share, by Country (2025) |
FIGURE 15 Competitive Landscape — Market Share Analysis (2025) |
FIGURE 16 Competitive Landscape — Strategic Group Mapping

Certified Researchers

Customize Report

Segmentation Quick Reference

Dimension	Sub-Segments	Dominant Segment	Fastest Growing Segment
By Product	Single-Use Bioreactors, Filtration Assemblies, Sensors & Analytics, Bags/Tubing/Connectors, Mixing Systems	Single-Use Bioreactors (~42% share)	Sensors & Analytics (17.5% CAGR)
By Workflow Stage	Upstream Processing, Downstream Processing, Other Operations	Upstream Processing (~57% share)	Downstream Processing (14.6% CAGR)
By End User	Biopharmaceutical Companies, CDMOs, Academic & Research Institutions	Biopharmaceutical Companies (~69.5% share)	CDMOs (16.0% CAGR)
By Scale	Commercial Scale, Clinical Scale	Commercial Scale (~72% share)	Clinical Scale (14.5% CAGR)
By Geography	North America, Europe, Asia-Pacific, South America, Middle East & Africa	North America (38.2% share)	Asia-Pacific (14.2% CAGR)

Market Segmentation Overview

By Product

Sub-Segment	Key Trend
Single-Use Bioreactors	Scale-up to 4,000–6,000 L systems; competition driving 8–12% ASP declines
Filtration Assemblies	Membrane chromatography replacing resin columns for mAb purification
Sensors & Analytics	Disposable Raman and capacitance probes enabling real-time AI process control
Bags, Tubing & Connectors	Aseptic connector standardization reducing vendor lock-in
Mixing Systems	Automated buffer and media preparation with integrated PAT

The product landscape is evolving from commodity consumables toward integrated smart assemblies that combine fluid management with embedded sensing and data connectivity.

By Workflow Stage

Sub-Segment	Key Trend
Upstream Processing	High-density cell culture and perfusion driving bioreactor and media bag demand
Downstream Processing	Single-use TFF and membrane chromatography gaining share from stainless purification trains
Other Operations	Pre-sterilized filling and storage kits for final drug substance handling

Upstream operations anchor the revenue base, while downstream single-use adoption accelerates as high-titer processes demand faster purification turnaround.

By End User

Sub-Segment	Key Trend
Biopharmaceutical Companies	Captive facility modernization; blockbuster biologic production at scale
CDMOs	Multi-product facility design; rapid changeover as competitive differentiator
Academic & Research Institutions	Grant-funded process development; clinical-stage manufacturing partnerships

CDMOs are reshaping procurement patterns by standardizing on single-use platforms across their global facility networks.

By Scale

Sub-Segment	Key Trend
Commercial Scale	Dominant revenue contributor; growing consumable intensity per approved biologic
Clinical Scale	Expanding biologics pipeline driving process development consumable demand

Commercial-scale operations consume the highest volume per campaign, while clinical scale benefits from the sheer number of new molecules entering trials annually.

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”